As our regular readers will be well aware, there have been a number of published papers suggesting associations between the use of statins and other lipid-lowering agents and risk for diagnosis with and progression of prostate cancer over time. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: agent, lipid, lowering, Prevention, statin | 3 Comments »
A report on the UroToday web site has addressed a presentation given this week at the ESMO 2018 Congress in Munich, Germany, that is relevant to the potential value of taking a statin while you are being treated for very late stage prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cabazitaxel, data, interpretation, outcome, statin | 1 Comment »
It is relatively common knowledge — although never actually proven in a large, randomized, placebo-controlled trial — that statins like rosuvastatin (Crestor) and atorvastatin (Lipitor) may be helpful in the management of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: African American, race, risk, statin, Treatment | 13 Comments »
A recent article in the Journal of Clinical Oncology, together with an associated editorial, have addressed the issue of whether evidence is now sufficient to argue that all men with prostate cancer should be treated with a statin. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: mortality, progression, risk, statin, Treatment | 8 Comments »
A recent data analysis for the Danish national health registry systems has once again provided confirmation of a link between statin use and risk of prostate cancer-specific mortality. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: Diagnosis, mortality, rate, statin, survival, therapy | 3 Comments »
In a commentary a couple of days ago we noted some diversity among medical opinion leaders about the safety of treatment with statins. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: mortality, risk, side effect, statin, Treatment | 2 Comments »
The question of whether or not to take a statin to either prevent or actually help in the treatment of prostate cancer has potentially just become moot for many men in America … thanks to new guidance from the US Preventive Services Task Force (USPSTF). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: Prevention, risk, statin, Treatment | 7 Comments »
A recent review article in the journal Nature Reviews: Urology has concluded that, while we are learning a lot more about the potential role(s) of statins in the prevention and management of prostate cancer, we still have no definitive evidence of their value. … READ MORE …
Filed under: Management, Prevention, Risk, Treatment | Tagged: delay, Prevention, progression, risk, statin | 3 Comments »
Yet another large, epidemiological study has shown a clear link between taking statins and a reduced risk for cancer-specific death (prostate cancer included). … READ MORE …
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: mortality, risk, statin, trial | 1 Comment »
Data from the North Carolina-Louisiana Prostate Cancer Project, a projected funded by the Department of Defense’s Prostate Cancer Research Program, have again shown that diets high in saturated fats seem to increase risk for aggressive forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: aggressiveness, diet, fat, risk, saturated, statin, unsaturated | Leave a comment »
According to a media release and a presentation given at the European Association of Urology (EAU) in Europe this week, statin therapy has a small but significant impact on overall and prostate cancer-specific mortality rates. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: all-cause, cancer-specific, mortality, prostate, statin, survival | 6 Comments »
Yet another study involving a large number of patients (this one from Taiwan) has again concluded that men with prostate cancer who take statins are less likely to die within a definable time period than men with prostate cancer who are not taking statins. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: mortality, overall, risk, statin | 2 Comments »
In the past few years we have become used to seeing data from a range of studies suggesting that ongoing statin therapy is associated with both a lowered risk for diagnosis with prostate cancer and beneficial impact on the outcomes of treatment for prostate cancer once diagnosed. However, … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: Diagnosis, ethnicity, race, risk, statin | Leave a comment »
A newly published article in JAMA Oncology has now suggested that adding a statin to a patient’s treatment regimen at initiation of androgen deprivation therapy (ADT) may significantly impact time to disease progression among men diagnosed with progressive, hormone-sensitive prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, advanced, androgen, deprivation, hormone-sensitive, progressive, statin | 3 Comments »
A combination of two studies by a group of researchers at the Dana-Farber Cancer Institute in Boston has provided some further evidence of the potential benefits of statin therapy for men being treated with androgen deprivation therapy (ADT) … but the evidence is preliminary and needs validation. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, deprivation, progression-free, statin, survival | 6 Comments »
